Scinai acquires Recipharm

Scinai agreed to acquire Recipharm. Reported deal value: Undisclosed. Status: Completed. Sector: Biopharmaceutical. Target headquarters context: Stockholm, Stockholm, Sweden.

This page summarizes publicly available information about the transaction as of 2026-02-17. Figures and status may change as filings and press coverage update.

As a result of the acquisition and the collaboration agreement, Scinai expanded capabilities will now cover recombinant proteins, small molecules, peptides, antibodies and oligonucleotides through a combination of internal capabilities and collaboration with Recipharm .Acquisition of Recipharm Israel Ltd.Under the terms of the Share Purchase Agreement, Scinai has acquired Recipharm Israel Ltd., which operates a cGMP manufacturing site in Yavne, Israel , providing early chemistry development and small-scale manufacturing of active pharmaceutical ingredients for biopharmaceutical customers' c...